Alexandre Vimont
15 Papers
Alexandre Vimont is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.
Sophie Béliard,Franck Boccara,Bertrand Cariou,Alain Carrié,Xavier Collet,Michel Farnier,Jean Ferrières,Michael Krempf,Noël Peretti,Jean-Pierre Rabès,René Valéro,Alexandre Vimont,Mathilde Varret,Sybil Charrière,Eric Bruckert,Denis Angoulvant,S. Beliard,Pascale Benlian,Catherine Boileau,Valérie Carreau,Mathilde Di Filippo,Pierre-Henri Ducluzeau,Sonia Dulong,V. Durlach,E. Ferrari,Antonio Gallo,P. Girardet,Régis Hankard,D. Lalau,Bruno Lefort,Julie Lemale,P. Moulin,F. Paillard,Alain Pradignac,Y. Pucheu,Samir Saheb,Ariane Sultan,Patrick Tounian,R. Valéro,B. Vergès,Cécile Yelnik,Olivier Ziegler +41 more
TL;DR: The rate of recurrent cardiovascular events was high in French patients with HeFH in secondary prevention and the detection of FH during childhood is crucial to prevent CV events at a young age by early initiating statin therapy.
42
Factors predicting statin initiation during childhood in familial hypercholesterolemia: importance of genetic diagnosis.
Nicole Arielle Peretti,Alexandre Vimont,Emmanuel Mas,Jean Ferrières,Patrick Tounian,Julie Lemale,Franck Boccara,Mathilde Di Filippo,Sybil Charrière,Pierre Poinsot,Yves Cottin,P-H. Ducluzeau,C. Dourmap,Bernard Cariou,Michel Farnier,F. Paillard,A. Pradignac,Cécile Yelnik,Ana-Maria Gallo,Eric Bruckert,Sophie Béliard +20 more
TL;DR: In this paper , the authors identify childhood and parental factors associated with initiation of statin therapy in children with heterozygous familial hypercholesterolemia (HeFH), including underlying genetic diagnosis or parental premature atherosclerotic cardiovascular disease (ASCVD).
8
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study
P. Richard,Anne-Marie Fillet,Lucile Malard,Carole Leclerc,Claire Chanut,Geneviève Woimant,Chantal Jacquot,Henri Leleu,Pascal Morel,Alexandre Vimont +9 more
TL;DR: In this article , a ferritin testing policy for whole blood donors may prevent iron deficiency (ID) and anaemia, but may induce donation losses, and the authors aimed to estimate its impact on ID, anaemias and whole blood donations among donors at high risk of ID.
7
Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
Jean Ferrières,Michel Farnier,Eric Bruckert,Alexandre Vimont,V. Durlach,A. Ferrari,A Gallo,Franck Boccara,Dorota Ferrieres,Sophie Béliard,Denis Angoulvant,Karine Aouchiche,Bertrand Cariou,Valérie Carreau,Alain Carrié,S. Charrieres,Yves Cottin,Mathilde Di Filippo,C. Dourmap,Pierre-Henri Ducluzeau,Régis Hankard,Jocelyn Inamo,Olga Kalmykova,Michel Krempf,Julie Lemale,Philippe Moulin,F. Paillard,Noël Peretti,Agnes Perrin,A. Pradignac,Yann Pucheu,Jean-Pierre Rabès,Rachel Reynaud,Vincent Rigalleau,Francois Schiele,Ariane Sultan,Patrick Tounian,René Valéro,Bruno Vergès,Cécile Yelnik,Olivier Ziegler +40 more
TL;DR: In this article , the authors evaluated the long-term cardiovascular risk of heterozygous familial hypercholesterolemia using the French REgistry of Familial hypERCHOLesterolemia (this articleERCHOL).
7
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
Camille Verry,Sébastien Vincendeau,Marc Massetti,M. Blachier,Alexandre Vimont,Marie-Laure Bazil,P. Bernardini,Ségolène Pettré,Marc-Olivier Timsit +8 more
TL;DR: The impact of castration-resistant prostate cancer patients with metastasis (mCRPC) remains unclear as mentioned in this paper , and the impact of natural history and therapeutic management on the outcomes of mCRPC patients remains unclear.